Mostrar el registro sencillo del ítem

Artículo

dc.creatorSánchez Molina, Saraes
dc.creatorFiguerola Bou, Elisabetes
dc.creatorBlanco, Enriquees
dc.creatorSánchez Jiménez, Maríaes
dc.creatorTáboas, Pabloes
dc.creatorGómez, Soledades
dc.creatorÁlava Casado, Enrique dees
dc.date.accessioned2023-05-17T09:20:14Z
dc.date.available2023-05-17T09:20:14Z
dc.date.issued2020
dc.identifier.citationSánchez Molina, S., Figuerola Bou, E., Blanco, E., Sánchez Jiménez, M., Táboas, P., Gómez, S. y Álava Casado, E.d. (2020). RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis. Science Advances, 6 (43), 1-16. https://doi.org/10.1126/sciadv.aba3058.
dc.identifier.issn2375-2548es
dc.identifier.urihttps://hdl.handle.net/11441/146183
dc.description.abstractEwing sarcoma (EwS) is an aggressive tumor that affects adolescents and young adults. EwS is defined by a chromosomal translocation, EWSR1-FLI1 being the most common, that causes genome reprogramming through remodeling of enhancers. Here, we describe an unexpected function of RING1B, which is highly expressed in EwS. While retaining its repressive activity at Polycomb developmental regulated genes, RING1B colocalizes with EWSR1-FLI1 at active enhancers. We demonstrate that RING1B is necessary for the expression of key EWSR1-FLI1 targets by facilitating oncogene recruitment to their enhancers. Knockdown of RING1B impairs growth of tumor xenografts and expression of genes regulated by EWSR1-FLI1 bound enhancers. Pharmacological inhibition of AURKB with AZD1152 increases H2Aub levels causing down-regulation of RING1B/EWSR1-FLI1 common targets. Our findings demonstrate that RING1B is a critical modulator of EWSR1-FLI1–induced chromatin remodeling, and its inhibition is a potential therapeutic strategy for the treatment of these tumors.es
dc.description.sponsorshipAsociación Española Contra el Cáncer (AECC) GCB13131578es
dc.description.sponsorshipAsociación Pablo Ugarte (APU)es
dc.description.sponsorshipInstituto de Salud Carlos III PI16/00245es
dc.description.sponsorshipMinisterio de Economía, Industria y Competitividad (MEIC) BFU2016-75008-Pes
dc.description.sponsorshipFundación Vencer el Cáncer (VEC)es
dc.formatapplication/pdfes
dc.format.extent16es
dc.language.isoenges
dc.publisherAmerican Association for the Advancement of Sciencees
dc.relation.ispartofScience Advances, 6 (43), 1-16.
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectEwing sarcoma (EwS)es
dc.subjectTumorigenesises
dc.subjectTumorses
dc.subjectAdolescentses
dc.subjectChromosomal translocationes
dc.subjectGenomees
dc.subjectYoung Adultses
dc.subjectPharmacological inhibitiones
dc.titleRING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesises
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Citología e Histología Normal y Patológicaes
dc.identifier.doi10.1126/sciadv.aba3058es
dc.contributor.groupUniversidad de Sevilla. CTS1035: Patología Molecular del Cáncer Sólidoes
dc.journaltitleScience Advanceses
dc.publication.volumen6es
dc.publication.issue43es
dc.publication.initialPage1es
dc.publication.endPage16es

FicherosTamañoFormatoVerDescripción
RING1B recruits EWSR1_FLI1.pdf2.902MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución-NoComercial 4.0 Internacional